New Rituximab Biosimilar Now Available! + Actemra Auto Injector & Pre-filled Syringe Approved by EAP!

Effective today, March 31, Truxima (rituximab) has new LU codes for RA. Here is the information shared by the Ministry:

Truxima (rituximab) 100mg/10mL, 500mg/50mL – Inj Sol (CEH)

LU Code 575
For the treatment of adults with severe active rheumatoid arthritis (RA) (greater than or equal to 5 swollen joints, and rheumatoid factor positive and/or anti-CCP positive, and radiographic evidence of rheumatoid arthritis) who meet clinical criteria. For complete details, please visit the March 2020 Summary of Changes document at http://www.health.gov.on.ca/en/pro/programs/drugs/edition_43.aspx.

LU Code 576
For the re-treatment of patients with severe active rheumatoid arthritis (RA) (greater than or equal to 5 swollen joints, and rheumatoid factor positive and/or anti-CCP positive, and radiographic evidence of rheumatoid arthritis) who meet clinical criteria. For complete details, please visit the March 2020 Summary of Changes document at http://www.health.gov.on.ca/en/pro/programs/drugs/edition_43.aspx.

As well, please note that we have updated the ORA pJIA EAP form so that the Actemra pre-filled syringe has been added as a format for the pJIA indication. We have updated our website with the new form, which you may access here: ORA pJIA EAP Form